about
Cardiac remodeling in obesityHeart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationQTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the hypertension genetic epidemiology network studyGuidelines for arterial hypertension: the echocardiography controversy.Should all patients with hypertension have echocardiography?Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study.Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study.Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity.Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease.Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study.Cardiac geometry and function in diabetic or prediabetic adolescents and young adults: the Strong Heart Study.Left ventricular geometry and hypotension in end-stage renal disease: a mechanical perspective.Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart StudySerial echocardiographic assessment of left ventricular mass: how blinded should readers be?Early markers of right heart involvement in regular smokers by Pocket Size Imaging Device.Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study.Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the Strong Heart Study.Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study.Insufficient control of blood pressure and incident diabetesInsulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study.Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study.Hypertensive target organ damage predicts incident diabetes mellitus.Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study.Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the Strong Heart Study.Left ventricular geometry in obesity: Is it what we expect?Influence of Left Ventricular Stroke Volume on Incident Heart Failure in a Population With Preserved Ejection Fraction (from the Strong Heart Study).Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long-Axis View.Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).High pulse pressure as a marker of preclinical cardiovascular disease.Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: the Campania Salute Network.Method errors or unexplained biological information?Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia.Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events.Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.Response to are observational studies more informative than randomized controlled trials in hypertension? Con side of the argument.Relations of pulse pressure and other components of blood pressure to preclinical echocardiographic abnormalities.Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study e
P50
Q26827207-BED3BB08-B90E-432A-93AB-31B4D2D7B067Q28303699-BB2ABFCB-13C0-4961-9221-27D508E3C4C2Q29547236-0DE31CBC-8B6C-435F-8FE7-DE4F8286D6D9Q33387714-B6E3DA01-3E87-44A3-9788-8699E8920E20Q33718874-69B271DA-248A-4F59-A25B-495F228FF10FQ33986193-5F1694F5-226F-460B-BDC3-C23BB415547DQ34071389-9D32C4E5-DBF8-4655-8081-AC67C13B0599Q34423669-34043924-FBD1-48CC-A19E-7D83541A6927Q34602438-F93C1648-3DBC-4D50-873D-20AC2A327EE2Q34764813-44493180-8935-4987-A788-6678A5337E90Q35179903-CD255316-FD53-45A0-BCA1-1093157464AAQ35225391-5E1F2AE1-176E-46FB-AAAA-DB9523E6BEF5Q35545698-DFAAB00E-DD7C-450B-99E4-39D35FA0AA0DQ35633918-890CF1AD-20D1-4ECF-A15F-1A56741CACBDQ35671382-E7FF8992-97BF-4396-83BD-6DD8CC03F7ADQ35862964-5E23DB2F-39B2-45DA-9F65-ACE66687EDBEQ35879108-AEABD51E-C6D7-4B3D-8D69-E47FE5C276B4Q36712178-1DE758A1-E24C-4191-A07D-EB2DC02BC31CQ36958792-ACA094A9-DD00-4BE5-A89E-511EFAF269D2Q37145949-E9E93B9E-E9F2-42A9-A2B8-F81B0EBB844CQ37163767-483346B6-F15C-4C30-A056-C45DAB0F4778Q37193499-C867227E-3CC1-48CC-BC06-BE98281182C7Q37311398-6AE35BD6-A9EA-4982-BB8B-C5B29D8D16F7Q37330853-9F65692C-4D84-4D5F-B2BB-88FAB3D2A25EQ37418437-D61D4232-8539-4F40-938E-7BA6E2D870ACQ37647845-408E66FE-BCC5-4A5A-8810-6B22229E0AB4Q38149591-23916534-6EC1-4B0A-A722-430AA5DF452EQ38980303-FB96BCAE-645B-40F4-A5ED-B394A62EC073Q39042272-10254D36-86D2-412A-BF6E-B21D70233162Q39230151-4216B62E-2F5A-415E-9A11-3F1C6072B839Q39941985-662C3F8C-CBC9-418D-86F8-8F5820FDA979Q40347869-FC5E6390-4D1F-4F46-8F3A-DB295F928483Q41540096-4EE6CBDD-9215-4E55-840A-B5EE4B75252BQ42821624-B2926DA2-2A58-4F94-9B5A-553BA62789E1Q43055297-D14FCD6F-0162-4539-BE9C-B4F484D127B1Q43436279-CFF0E5B9-CEFF-4142-8ECF-A5EF78A859C0Q43587108-B298D525-1A43-4F10-8194-BF6CFB242DEEQ43617472-D7733191-14DD-4878-862E-1532602C4ACAQ43699613-C984F590-B9E6-4901-8955-FCD32D8ACC8EQ43733943-BF7453B4-BD8C-422D-ABFA-ED57BDA28483
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanni de Simone
@ast
Giovanni de Simone
@en
Giovanni de Simone
@es
Giovanni de Simone
@nl
Giovanni de Simone
@sl
type
label
Giovanni de Simone
@ast
Giovanni de Simone
@en
Giovanni de Simone
@es
Giovanni de Simone
@nl
Giovanni de Simone
@sl
prefLabel
Giovanni de Simone
@ast
Giovanni de Simone
@en
Giovanni de Simone
@es
Giovanni de Simone
@nl
Giovanni de Simone
@sl
P1053
D-1767-2011
P106
P1153
55515626600
P21
P31
P3829
P496
0000-0001-8567-9881